Saturday, September 1, 2012

Equaline Allergy Relief



loratadine

Dosage Form: tablet
SuperValu Allergy Relief Drug Facts

Active ingredient (in each tablet)


Loratadine 10 mg



Purpose


Antihistamine



Uses


temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:


  • runny nose

  • sneezing

  • itchy, watery eyes

  • itching of the nose or throat


Warnings



Do not use


if you have ever had an allergic reaction to this product or any of its ingredients



Ask a doctor before use if you have


liver or kidney disease. Your doctor should determine if you need a different dose.



When using this product


do not take more than directed. Taking more than directed may cause drowsiness.



Stop use and ask a doctor if


an allergic reaction to this product occurs. Seek medical help right away.



If pregnant or breast-feeding,


ask a health professional before use.



Keep out of reach of children.


In case of overdose, get medical help or contact a Poison Control Center right away.



Directions









adults and children 6 years and over1 tablet daily; not more than 1 tablet in 24 hours
children under 6 years of ageask a doctor
consumers with liver or kidney diseaseask a doctor

Other information


  • do not use if blister unit is broken or torn (Blister Only)

  • do not use if printed foil under cap is broken or missing (Bottle Only)

  • store at 20°-25°C (68°-77°F)

  • protect from excessive moisture (Blister Only)


Inactive ingredients


lactose monohydrate, magnesium stearate, povidone, pregelatinized starch



Questions or comments?


1-877-932-7948



Principal Display Panel


Compare to Claritin® Tablets active ingredient


Non-Drowsy*


Allergy Relief


Loratadine Tablets, 10 mg/Antihistamine


Indoor & Outdoor Allergies


24 Hour Relief of:


Sneezing


Itchy, Watery Eyes


Runny Nose


Itchy Throat or Nose


Actual Size


Original Prescription Strength


*When taken as directed. See Drug Facts Panel.


Allergy Relief Carton










Equaline Allergy Relief 
loratadine  tablet










Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)41163-612
Route of AdministrationORALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LORATADINE (LORATADINE)LORATADINE10 mg





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
ColorWHITEScoreno score
ShapeOVALSize8mm
FlavorImprint CodeL612
Contains      






















































Packaging
#NDCPackage DescriptionMultilevel Packaging
141163-612-461 BLISTER PACK In 1 CARTONcontains a BLISTER PACK
110 TABLET In 1 BLISTER PACKThis package is contained within the CARTON (41163-612-46)
241163-612-651 BOTTLE In 1 CARTONcontains a BOTTLE
230 TABLET In 1 BOTTLEThis package is contained within the CARTON (41163-612-65)
341163-612-721 BOTTLE In 1 CARTONcontains a BOTTLE
360 TABLET In 1 BOTTLEThis package is contained within the CARTON (41163-612-72)
441163-612-751 BOTTLE In 1 CARTONcontains a BOTTLE
490 TABLET In 1 BOTTLEThis package is contained within the CARTON (41163-612-75)
541163-612-602 BLISTER PACK In 1 CARTONcontains a BLISTER PACK
510 TABLET In 1 BLISTER PACKThis package is contained within the CARTON (41163-612-60)
641163-612-951 BOTTLE In 1 CARTONcontains a BOTTLE
645 TABLET In 1 BOTTLEThis package is contained within the CARTON (41163-612-95)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07630102/07/2005


Labeler - Supervalu Inc (006961411)
Revised: 09/2009Supervalu Inc




More Equaline Allergy Relief resources


  • Equaline Allergy Relief Side Effects (in more detail)
  • Equaline Allergy Relief Dosage
  • Equaline Allergy Relief Use in Pregnancy & Breastfeeding
  • Equaline Allergy Relief Drug Interactions
  • 0 Reviews for Equaline Allergy Relief - Add your own review/rating


Compare Equaline Allergy Relief with other medications


  • Hay Fever
  • Urticaria

No comments:

Post a Comment